Factors affecting the outcome of frozen-thawed embryo transfer. 2013

Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
Department of Obstetrics and Gynecology, University of Oulu, Oulu, Finland. zdravka.veleva@helsinki.fi

OBJECTIVE Which clinical and laboratory factors affect live birth rate (LBR) after frozen-thawed embryo transfer (FET)? CONCLUSIONS Top quality embryo characteristics, endometrial preparation protocol, number of embryos transferred and BMI affected independently the LBR in FET. BACKGROUND FET is an important part of present-day IVF/ICSI treatment. There is limited understanding of the factors affecting success rates after FET. METHODS This is a two-centre retrospective cohort study. Analysis was carried out on 1972 consecutive FET cycles in 1998-2007, with embryos frozen on Day 2. The primary outcome was LBR per cycle. METHODS We assessed the independent effect on LBR of the following variables: female age, female age at embryo freezing, BMI, diagnosis, primary versus secondary infertility, fertilization by IVF versus ICSI, pregnancy in the fresh cycle, type (spontaneous, spontaneous with luteal progesterone and estrogen/progesterone substitution) and rank of the FET cycle, as well as number and presence (yes versus no) of top quality embryo(s) at freezing, thawing and transfer, damaged thawed embryos and overnight culture. RESULTS In 78% of the cycles with top quality embryos frozen (n = 1319), at least one embryo still had high-quality morphology after thawing. Top quality embryo morphology observed at any stage of culture improved the outcome even if high-quality characteristics disappeared before transfer. LBRs after the transfer of a top quality embryo were similar in the FET (24.9%) and fresh cycles of the same period (21.9%). The chance of live birth increased significantly if ≥1 top quality embryo was present at freezing (odds ratio (OR) 1.85, 95% confidence interval (CI) 1.10-3.14), at thawing (OR 1.93, CI 1.20-3.11) or at transfer (OR 3.41, CI 2.12-5.48). Compared with spontaneous cycles with luteal support, purely spontaneous cycles (OR 0.58, CI 0.40-0.84) and hormonally substituted FET (OR 0.47, CI 0.32-0.69) diminished the odds of pregnancy. BMI (OR 0.96, CI 0.92-0.99) and transfer of two embryos versus one (OR 1.45, CI 1.08-1.94) were other factors that improved LBR after FET. CONCLUSIONS The sample sizes available in some subanalyses were small, limiting the power of the study. CONCLUSIONS The presence of ≥1 top quality embryo at any step of the freezing and thawing process increases the chance of pregnancy. The data do not support the freezing of all embryos for transfer in order to improve the outcome. A top quality embryo transferred in FET may even have the same potential as in a fresh cycle. On the contrary, LBR in the group with no top quality embryos frozen was quite low (10.4%), raising the question of whether a re-evaluation of freezing criteria is necessary to avoid costly treatments with a low success rate.

UI MeSH Term Description Entries
D007247 Infertility, Female Diminished or absent ability of a female to achieve conception. Sterility, Female,Sterility, Postpartum,Sub-Fertility, Female,Subfertility, Female,Female Infertility,Female Sterility,Female Sub-Fertility,Female Subfertility,Postpartum Sterility,Sub Fertility, Female
D007248 Infertility, Male The inability of the male to effect FERTILIZATION of an OVUM after a specified period of unprotected intercourse. Male sterility is permanent infertility. Sterility, Male,Sub-Fertility, Male,Subfertility, Male,Male Infertility,Male Sterility,Male Sub-Fertility,Male Subfertility,Sub Fertility, Male
D008297 Male Males
D010062 Ovulation Induction Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum. Ovarian Stimulation,Ovarian Stimulations,Stimulation, Ovarian,Stimulations, Ovarian
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011786 Quality Control A system for verifying and maintaining a desired level of quality in a product or process by careful planning, use of proper equipment, continued inspection, and corrective action as required. (Random House Unabridged Dictionary, 2d ed) Control, Quality,Controls, Quality,Quality Controls
D001723 Birth Rate The number of births in a given population per year or other unit of time. Natality,Age-Specific Birth Rate,Age-Specific Fertility Rate,Fertility Rate,Age Specific Birth Rate,Age Specific Fertility Rate,Age-Specific Birth Rates,Age-Specific Fertility Rates,Birth Rate, Age-Specific,Birth Rates,Fertility Rate, Age-Specific,Fertility Rates,Natalities,Rate, Age-Specific Fertility,Rate, Birth,Rate, Fertility
D001755 Blastocyst A post-MORULA preimplantation mammalian embryo that develops from a 32-cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. The inner cell mass gives rise to the embryonic disc and eventual embryo proper. Embryo, Preimplantation,Blastocysts,Embryos, Preimplantation,Preimplantation Embryo,Preimplantation Embryos
D004477 Ectogenesis Embryonic and fetal development that takes place in an artificial environment in vitro. Ectogeneses
D004624 Embryo Transfer The transfer of mammalian embryos from an in vivo or in vitro environment to a suitable host to improve pregnancy or gestational outcome in human or animal. In human fertility treatment programs, preimplantation embryos ranging from the 4-cell stage to the blastocyst stage are transferred to the uterine cavity between 3-5 days after FERTILIZATION IN VITRO. Blastocyst Transfer,Tubal Embryo Transfer,Tubal Embryo Stage Transfer,Embryo Transfers,Transfer, Embryo,Transfers, Embryo

Related Publications

Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
June 2011, Taiwanese journal of obstetrics & gynecology,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
August 2021, Zhonghua yi xue za zhi,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
June 2023, Archives of gynecology and obstetrics,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
July 2017, Reproductive medicine and biology,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
January 2023, Evidence-based complementary and alternative medicine : eCAM,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
December 2009, Hong Kong medical journal = Xianggang yi xue za zhi,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
December 2013, Journal of assisted reproduction and genetics,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
January 2022, Frontiers in endocrinology,
Zdravka Veleva, and Mauri Orava, and Sinikka Nuojua-Huttunen, and Juha S Tapanainen, and Hannu Martikainen
May 2016, Journal of assisted reproduction and genetics,
Copied contents to your clipboard!